Raymond James & Associates’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,780
| Closed | -$529K | – | 3752 |
|
|
2023
Q2 | $529K | Sell |
5,780
-204
| -3% | -$18.7K | ﹤0.01% | 2884 |
|
|
2023
Q1 | $440K | Sell |
5,984
-402
| -6% | -$29.6K | ﹤0.01% | 2969 |
|
|
2022
Q4 | $533K | Sell |
6,386
-1,653
| -21% | -$138K | ﹤0.01% | 2846 |
|
|
2022
Q3 | $778K | Sell |
8,039
-1,396
| -15% | -$135K | ﹤0.01% | 2547 |
|
|
2022
Q2 | $992K | Sell |
9,435
-1,666
| -15% | -$175K | ﹤0.01% | 2448 |
|
|
2022
Q1 | $1.91M | Buy |
11,101
+680
| +7% | +$117K | ﹤0.01% | 2157 |
|
|
2021
Q4 | $1.69M | Sell |
10,421
-6,680
| -39% | -$1.08M | ﹤0.01% | 2287 |
|
|
2021
Q3 | $2.55M | Buy |
17,101
+6,473
| +61% | +$965K | ﹤0.01% | 1918 |
|
|
2021
Q2 | $2.6M | Buy |
10,628
+169
| +2% | +$41.4K | ﹤0.01% | 1911 |
|
|
2021
Q1 | $2.77M | Sell |
10,459
-3,874
| -27% | -$1.03M | ﹤0.01% | 1802 |
|
|
2020
Q4 | $4.2M | Buy |
14,333
+152
| +1% | +$44.6K | ﹤0.01% | 1439 |
|
|
2020
Q3 | $3.35M | Sell |
14,181
-526
| -4% | -$124K | ﹤0.01% | 1433 |
|
|
2020
Q2 | $2.92M | Buy |
14,707
+722
| +5% | +$143K | ﹤0.01% | 1494 |
|
|
2020
Q1 | $2.57M | Buy |
13,985
+6,964
| +99% | +$1.28M | ﹤0.01% | 1435 |
|
|
2019
Q4 | $1.17M | Buy |
7,021
+1,017
| +17% | +$170K | ﹤0.01% | 2171 |
|
|
2019
Q3 | $787K | Sell |
6,004
-1,079
| -15% | -$141K | ﹤0.01% | 2326 |
|
|
2019
Q2 | $860K | Sell |
7,083
-695
| -9% | -$84.4K | ﹤0.01% | 2299 |
|
|
2019
Q1 | $959K | Buy |
7,778
+596
| +8% | +$73.5K | ﹤0.01% | 2225 |
|
|
2018
Q4 | $841K | Buy |
7,182
+3,255
| +83% | +$381K | ﹤0.01% | 2186 |
|
|
2018
Q3 | $491K | Buy |
+3,927
| New | +$491K | ﹤0.01% | 2706 |
|
|
2017
Q3 | – | Sell |
-3,378
| Closed | -$212K | – | 3256 |
|
|
2017
Q2 | $212K | Buy |
+3,378
| New | +$212K | ﹤0.01% | 2919 |
|